|
FY2025
12 months to Nov 30, 2025
|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
FY2021
12 months to Nov 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Impairment of public inventory | |||||
| Impairment of investment - Tianhe stock | |||||
| Impairment of assets | |||||
| Change in fair value of contingent consideration | |||||
| Loss on sale of property and equipment | |||||
| Losses (gains) on marketable securities | |||||
| Unrealized gain on interest rate swap contract | |||||
| Compensatory element of stock options | |||||
| Provision for doubtful accounts | |||||
| Deferred income tax benefit | |||||
| Amortization of debt issuance costs | |||||
| Amortization of operating lease right-of-use asset | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Inventory | |||||
| Other current assets | |||||
| Deposits and other assets, net | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating lease liability | |||||
| Other liabilities | |||||
| Deferred revenue | |||||
| Net cash from operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Sale of property and equipment | |||||
| Payment of Duke license agreement | |||||
| Proceeds from liquidation of marketable securities | |||||
| Purchases of marketable securities | |||||
| Sale of marketable securities | |||||
| Net cash used in investing activities | |||||
| Cash flows used in financing activities: | |||||
| Treasury stock purchases | |||||
| Repayments of note payable | |||||
| Repayment of line of credit | |||||
| Proceeds from the exercise of stock options | |||||
| Proceeds from line of credit | |||||
| Proceeds from note payable | |||||
| Dividends paid | |||||
| Issuance costs associated with the proceeds from the note payable | |||||
| Proceeds from Swap termination | |||||
| Payment of Cord:Use earnout | |||||
| Net cash used in financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of period | |||||
| Cash and cash equivalents - end of period | |||||
| Supplemental non-cash operating activities: | |||||
| Lease liability arising from right-of-use asset | |||||
| Supplemental investing activities: | |||||
| Construction costs payable | |||||
| Supplemental cash flow information: | |||||
| Interest | |||||
| Income taxes | |||||
Loading...